These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3431698)

  • 1. Computed tomography brain changes in parkinsonian dementia.
    Inzelberg R; Treves T; Reider I; Gerlenter I; Korczyn AD
    Neuroradiology; 1987; 29(6):535-9. PubMed ID: 3431698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebral atrophy and dementia in Parkinson disease].
    Corthésy D; Hungerbühler JP; Assal G; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):75-85. PubMed ID: 2579429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral blood flow and brain atrophy correlated by xenon contrast CT scanning.
    Kitagawa Y; Meyer JS; Tanahashi N; Rogers RL; Tachibana H; Kandula P; Dowell RE; Mortel KF
    Comput Radiol; 1985; 9(6):331-40. PubMed ID: 3879209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of brain atrophy in Parkinson's disease. A CT scan study.
    Steiner I; Gomori JM; Melamed E
    Neuroradiology; 1985; 27(2):158-60. PubMed ID: 3990948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grey matter atrophy in early versus late dementia in Parkinson's disease.
    Beyer MK; Aarsland D
    Parkinsonism Relat Disord; 2008 Dec; 14(8):620-5. PubMed ID: 18394949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI study on Parkinson's disease in relation to the severity of the disease.
    Agnoli A; Gallucci M; Fabbrini G; Feliciani M; Ruggieri S; Conti F
    Adv Neurol; 1987; 45():103-6. PubMed ID: 3825689
    [No Abstract]   [Full Text] [Related]  

  • 13. The significance of cerebral atrophy for the symptomatology of Parkinson's disease.
    Schneider E; Fischer PA; Jacobi P; Becker H; Hacker H
    J Neurol Sci; 1979 Jul; 42(2):187-97. PubMed ID: 479910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's syndrome: cranial computed-tomography findings. Their dependence on sex and age.
    Grundl W; Ziegler R; Westphal KP; Hufnagl M; Szirtes J; Kornhuber HH
    Acta Med Hung; 1991; 48(3-4):127-36. PubMed ID: 1822851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
    Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic correlates of dementia in Parkinson's disease.
    Chui HC; Mortimer JA; Slager U; Zarow C; Bondareff W; Webster DD
    Arch Neurol; 1986 Oct; 43(10):991-5. PubMed ID: 3753274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.